Adam Walker’s Pharma Prescribed Podcast

By Adam Walker

Get ready for open and honest long-form conversations with fascinating and passionate individuals in clinical research.
These are people you may or may not be aware of, with one thing in common - ... more

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about Adam Walker’s Pharma Prescribed Podcast:

How many episodes does Adam Walker’s Pharma Prescribed Podcast have?

The podcast currently has 55 episodes available.

Adam Walker’s Pharma Prescribed Podcast episodes:

October 10, 2025 How to Predict a Trial's Failure Before It Happens (Using Fraud-Detection Maths)
Artem Adrianov on RBQM, Fraud Detection & the Young CEO Programme That Outperforms an MBA | Pharma Prescribed
Artem Adrianov — co-founder and CEO of CluePoints (SEG Integrity) and author of the Definitive Guide to RBQM — joins Adam Walker for a conversation about risk, quality, fraud detection and what it really means to build a company from its values up.
Artem holds a PhD in mathematical modelling and an Executive MBA from Cass Business School. He started by asking a simple question: how do you detect fraud in clinical trials? That led to Benford's Law, algorithms from the finance industry, and eventually a company that now manages risk across thousands of studies with 50 employees.
He also runs a Young CEO programme that has produced better leaders than any MBA — and the idea came from his wife's experience at Eli Lilly.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/5QsRaLzQgpZNhGn4Ru2cxO?si=e5c01721e0c846a5
Apple Podcasts → https://podcasts.apple.com/us/podcast/artem-adrianov-on-rbqm-fraud-detection-the-young-ceo/id1829715970?i=1000728560133
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://pharmaprescribed.podbean.com/
📖 WHAT WE COVER
- Fraud detection in pharma: Benford's Law and algorithms borrowed from finance
- "Bloomberg for pharma" — the vision for SEG Integrity
- The airplane analogy: 8 out of 10 flights delayed, 2 crash, and the price keeps doubling
- ICH E6 R3 knocking on the door — why the regulatory shift forces transformation
- The Young CEO programme: two years, psychologists, journaling and real strategic decisions
- 2–3% retention rate — and why internal promotion beats hiring from outside
- Founder-owned, self-funded and thinking long-term in a short-term industry
- "Reduced based monitoring" — what sites actually think RBM stands for
- Quality by design: why step-by-step always beats big bang
- Four-day quarterly fasting for clarity of mind — and what Socrates knew
- My RBQM Academy: 1,500+ professionals trained from 400+ organisations
- Piano, Sinatra's "My Way" and Bach played in jazz mode
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Artem Adrianov — co-founder of SEG Integrity
2:00 Four-day quarterly fasting for clarity of mind
3:00 Socrates, energy waves and hidden potential
4:00 Founding SEG: medicine, mathematics and solving challenging problems
5:00 Fraud detection in clinical trials — borrowing from finance
6:00 Benford's Law and digital repeatability algorithms
7:00 Every risk needs its own dedicated approach
8:00 Leadership style: removing roadblocks, not pointing fingers
9:00 The Young CEO programme explained
10:00 Real strategic decisions: "will you sign this contract?"
11:00 Why internal young leaders outperform hired-in managers
12:00 Two years, psychologists, journaling and transformation
13:00 Culture gets cemented through internal promotion
14:00 Apprenticeship model: learning through real decisions
15:00 Opening the programme to external participants
16:00 Eli Lilly and Johnson & Johnson as inspiration
17:00 AI and scaling: 50 people managing thousands of studies
18:00 ICH E6 R3 and why transformation is now mandatory
19:00 Revenue growth and 200–300 employees within two years
20:00 The airplane analogy: 8 out of 10 flights delayed, 2 crash
21:00 Comparing pharma to aviation safety standards
22:00 Bloomberg for pharma — transparent, benchmarked, insight-driven
23:00 Mutual decision-making, not finger pointing
24:00 Darwin: not the smartest, not the strongest — the most adaptable
25:00 Step-by-step always beats big bang in RBQM
26:00 "Reduced based monitoring" — what sites actually hear
27:00 Lessons as a founder: you can't do everything yourself
28:00 Quality in everything: ideas, implementation, delivery
29:00 Company fasting: reflecting on whether you deliver the best value
30:00 Quick-fire: believe in what you're doing despite all other opinions
31:00 Passion, patient stories and why you have to be a bit crazy
32:00 Piano, grand piano and everything with keys
33:00 Sinatra's "My Way" and Bach in jazz mode
34:00 Golden rule: stay integrated — doing the right thing when nobody's watching
👤 ABOUT ARTEM ADRIANOV
Co-founder and CEO of SEG Integrity. PhD mathematical modelling. Executive MBA (Cass). Author of the Definitive Guide to RBQM. Creator of My RBQM Academy (1,500+ professionals trained).
🌐 https://www.integrity.com
💼 Search "Artem Adrianov" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#ArtemAdrianov #SEGIntegrity #RBQM #QualityByDesign #ClinicalTrials #PharmaPrescribed #AdamWalker #FraudDetection #ICHE6R3 #ClinicalResearch #RiskManagement #YoungCEO #DataQuality #LifeSciences #CentralizedMonitoring
...more
43min
September 26, 2025 4:45am, February 24th, 2022: Running Clinical Trials Through a War
Dr. Anna Titkova on Building Clinical Trials in Ukraine War, COVID & Restarting | Pharma Prescribed
Dr. Anna Titkova — International Operations Director at Pratia and former Country Head of Pratia Ukraine — joins Adam Walker for one of the most deeply human conversations on the Pharma Prescribed Podcast.
Anna built Pratia Ukraine from scratch during COVID — registering two companies, establishing eight embedded clinical research units across four cities, randomising nearly 500 patients in a COVID vaccination trial. Then at 4:45am on February 24th, 2022, everything changed. Nearly 1,500 days later, she is still leading, still building, and still putting patients first — now from Poland.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/2zrjVn8j43Lqr4KaH7dM5a?si=oth7wUsURXm1Q4rEqWh40w
Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-anna-titkova-international/id1829715970?i=1000728557029
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://www.podbean.com/ew/pb-xgyvx-19770e6
📖 WHAT WE COVER
- Building Pratia Ukraine from zero during COVID — eight sites, four cities, three regions
- The first dedicated private clinical research institution in Ukraine
- 4:45am, February 24th, 2022 — and the 1,500 days that followed
- Relocating to Poland and rebuilding from a new country
- COVID as unconscious disaster recovery training for what came next
- 70 new trials approved in Ukraine in six months — approaching pre-war numbers
- "I wish I'd never told you this story" — the Oscar speech that frames everything
- Being a professor, a doctor, a mother and a business leader simultaneously
- Post-Soviet heritage: the bureaucratic reality of registering a clinical research site
- Why she still uses a paper list — and the satisfaction of crossing things off
- Patient centricity is not a phrase — it's access to innovative treatments wherever you are
- Warren Buffett on hiring: honesty, intelligence, energy — without the first, the rest don't matter
- 70 countries visited and what travel teaches about how small our worries really are
- You cannot take from the world more than you give to it
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Dr. Anna Titkova — International Operations Director, Pratia
2:00 1,500 days since the invasion — "we used to it now"
3:00 Born in Kharkiv — relocated to Poland
4:00 What Pratia does: an international site management organisation
5:00 Building Pratia Ukraine from 2019 — eight sites, four cities
6:00 Registering two companies during COVID lockdown
7:00 World best recruitment in a COVID treatment study — 500 patients
8:00 COVID as unconscious disaster recovery training
9:00 Adapting to impossible conditions — no transport, no notary, no normal
10:00 Family and purpose: a childhood dream to become a doctor
11:00 No businessman in the family — a post-Soviet mindset
12:00 "Your purpose is the rock you cannot imagine not doing"
13:00 Combining professor, doctor, mother and operations director
14:00 Cultural differences between Ukrainian legislation and EU standards
15:00 Paper lists and the satisfaction of crossing things off
16:00 Clinical trials in Ukraine today — 70 new approvals in six months
17:00 Sponsors remembering Ukraine's potential as a rescue country
18:00 Speaking at conferences and sharing the Ukrainian story
19:00 Operational excellence inside a site network
20:00 Resilience: not never falling, but rising with sharper vision
21:00 "The life has its own plans — and it humbles you"
22:00 "I wish I'd never made this film" — the Oscar speech
23:00 The future of Pratia and Anna's personal mission
24:00 Patient centricity means access — not a poster on a wall
25:00 Quick-fire: believe in yourself, no matter how impossible
26:00 Warren Buffett: honesty, intelligence, energy
27:00 Traveling 70 countries — how small our worries really are
28:00 Golden rule: you cannot take more than you give
👤 ABOUT DR. ANNA TITKOVA
International Operations Director at Pratia. Former Country Head, Pratia Ukraine. Associate Professor. Doctor. Mother.
🌐 https://www.pratia.com
💼 Search "Anna Titkova" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#AnnaTitkova #Pratia #Ukraine #ClinicalTrials #PharmaPrescribed #AdamWalker #SiteNetwork #Resilience #PatientAccess #ClinicalResearch #LifeSciences #WarAndResearch #COVID #Kharkiv #Poland
...more
36min
September 23, 2025 "You Don't Have to Be Like Everybody Else": The Mentor Who Built a Market
Natalie Douglas on Building Companies, Leading & Why Mentorship Changed Everything | Pharma Prescribed
Natalie Douglas — former CEO of Healthcare at Home, creator of the managed access market and Adam's mentor — joins Adam Walker for one of the most personally significant conversations on the Pharma Prescribed Podcast.
Natalie started carrying the bag at Janssen Pharmaceuticals. She was the only person on her training course without a biochemistry degree. Her trainer told her: "You don't have to be like everybody else." She wasn't — and she went on to build Idis (now Cgen) into the global market leader in managed access, secured private equity backing as one of the first women to do so in pharma services, and led a major turnaround at one of Europe's largest clinical homecare providers.
Adam calls her a mentor and a friend. This episode is their first recorded conversation.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/search/Natalie+Douglas+pharma+prescribed/episodes ⚠️ SWAP
Apple Podcasts → https://podcasts.apple.com/gb/search?term=Natalie+Douglas+pharma+prescribed ⚠️ SWAP
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://pharmaprescribed.podbean.com/
📖 WHAT WE COVER
- Carrying the bag at Janssen — and the trainer who said "just be yourself"
- Building Idis into a global market leader in managed access
- "Some people thought it might be illegal" — and how that market now serves millions
- First women in pharma services to secure PE backing — and why she wouldn't have been taken seriously with a smaller P&L
- Healthcare at Home: 150,000 patients a year and a turnaround under pressure
- Courage, confidence and calm — what leadership looks like in a storm
- Neurodiversity as a creative superpower
- Mentoring more men than women — and why she responds to every single request
- Leading from the back: what non-exec and chair roles taught her about quiet leadership
- Real world evidence in 2011 — and why it still hasn't moved fast enough
- "It's not a give back — it's a skillset that needs to be used"
- Trust, honesty, commitment and pace — the four fundamentals
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Natalie Douglas — mentor, friend, industry legend
2:00 How Adam and Natalie first connected in 2011
3:00 From Janssen sales rep to building Idis
4:00 Real world evidence in 2011 — and where it is today
5:00 Reality (now Cgen) and the pandemic pivot
6:00 What drives Natalie: natural curiosity, energy and a busy brain
7:00 Neurodiversity and creativity — "my brain hooks onto things others don't"
8:00 An explorer who loves people and asks a lot of questions
10:00 Early mentors: Sue Webb, Jane Griffiths, Liz Norton, Sadie Hartley
11:00 Family of sole traders — landing at J&J was intimidating
12:00 The only person without a biochemistry degree
13:00 "You don't have to be like everybody else"
14:00 Women in pharma leadership — then and now
16:00 Mentoring more men than women — honest feedback as a distinctive trait
17:00 First woman to secure PE backing in pharma services
18:00 "It takes courage to reach out and ask for help"
20:00 Honesty, listening, sense of humour — traits of great leadership
22:00 Healthcare at Home turnaround: courage, confidence and calm
24:00 Leading from the back — what non-exec taught her
26:00 Global Genes, British Growth Fund and how each role found her
28:00 Family, Switzerland, London, the US — an international unit
30:00 Quick-fire: find your mentors — 10 years earlier than I did
31:00 Trust, honesty, commitment and pace
32:00 Basketball, cooking, art, learning Italian
33:00 Golden rule: do something amazing — make a difference
👤 ABOUT NATALIE DOUGLAS
Former CEO of Healthcare at Home and Idis (now Cgen). Chair of two MedTech companies. PharmaVoice Top 100. Health Investor Power Top 50. EY Entrepreneur of the Year finalist.
💼 Search "Natalie Douglas" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#NatalieDouglas #HealthcareAtHome #Idis #ManagedAccess #PharmaPrescribed #AdamWalker #WomenInLeadership #FemaleFounder #Mentoring #PharmaLeadership #RealWorldEvidence #LifeSciences #NonExec #HealthcareInnovation #PatientAccess
...more
35min
September 21, 2025 A Cancer Scare Showed Him How Impossible Finding a Trial Really Is
Keith Berelowitz on PRxEngage, 35k Users in Month 1 & Why Patients Need North Star | Pharma Prescribed
Dr. Keith Berelowitz — founder and CEO of PRx Engage — joins Adam Walker for a conversation about patient engagement, self-determination theory and what it actually takes to build a clinical trial matching platform that patients trust.
Keith lost a friend at a young age. That drove him into science, then into bench research at the Royal Free, then into commercial clinical research at Richmond Pharmacology — where he and Adam first met. Years later, a personal cancer scare revealed how difficult it is to find a clinical trial, even for someone who works in the industry. PRx Engage was born from that experience.
35,000+ users in the first month. Five days to full funding. Oversubscribed.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/6lhc5JvQJf2Vdg9kWeCQzT?si=5dd931e0eeeb4804
Apple Podcasts → https://podcasts.apple.com/us/podcast/keith-berelowitz-on-prxengage-35k-users-in-month-1/id1829715970?i=1000727740938
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://pharmaprescribed.podbean.com/
📖 WHAT WE COVER
- A personal cancer scare — and realising even he got confused searching for trials
- PRx Engage: no login, no friction, trials matched by condition, age and location
- Self-determination theory: autonomy, competency and relatedness in patient engagement
- The dating app analogy: swipe right, swipe left — and why showing multiple trials works
- Decisional conflict and task completion: the three self-assessment tools
- Why showing only one sponsor's trial is the wrong approach
- 35,000+ users in month one — and a return rate of two to three visits
- Five days to full funding, oversubscribed — investors bought the team
- No login data collection: the ethos and the differentiator
- Cycling around London on TikTok — and discovering it actually works
- Trust across all stakeholders: why "them vs us" kills clinical research
- Gene editing, one-and-done therapies and what the future holds for our children
- "You can be direct without being disrespectful" — the golden rule
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Dr. Keith Berelowitz — founder of PRx Engage
3:00 Losing a friend young — and why that drove everything
4:00 A personal cancer scare and the search that changed his mind
5:00 Leaving Richmond to build PRx Engage
6:00 Purpose, ethics and paying it forward
8:00 "I actually do like people" — understanding patient stories
9:00 Authentic LinkedIn: writing everything himself
10:00 Meeting everyone who asks — you never know what you'll learn
12:00 Building a team that roams within a defined space
14:00 Patient journey walkthrough: no login, condition, age, location
16:00 Why showing multiple trials increases commitment
17:00 Self-assessment: medical suitability, decisional conflict, task completion
19:00 Mobile-first honesty — people tell their phone the truth
20:00 Connecting to the research site: the only point data is collected
22:00 Decentralised trials and travelling for research
24:00 Gamification, retention and the patient who wants to join the dev team
26:00 Startup lessons: highs and lows journal
28:00 35,000 users, amazing engineering team and industry veterans
30:00 Taking investment: five days to oversubscribed
32:00 Building tech is more expensive than people realise
34:00 "A patient's North Star" — resonating without pushing
36:00 Social media strategy: LinkedIn first, TikTok cycling second
38:00 Filming while cycling uphill — do not attempt
40:00 Trust: the thing most lacking across all stakeholders
42:00 Gene editing, one-and-done therapies and the next generation
44:00 Quick-fire: stop trying to impress people who don't get you
45:00 Low drama, high output — smart over slick
46:00 Cycling as daily thinking time
47:00 Golden rule: direct without disrespectful
49:00 prxengage.com — and Keith's email is public
👤 ABOUT DR. KEITH BERELOWITZ
Founder and CEO of PRx Engage. Chair, Fulham Research Ethics Committee. 20+ years in pharma and biotech research. Former Operations Director at Richmond Pharmacology.
🌐 https://www.prxengage.com
📧 [email protected]
💼 Search "Keith Berelowitz" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#KeithBerelowitz #PRxEngage #PatientEngagement #ClinicalTrials #PharmaPrescribed #AdamWalker #TrialMatching #SelfDeterminationTheory #PatientRecruitment #HealthTech #ClinicalResearch #LifeSciences #PatientAccess #StartupFounder #TrustInResearch
...more
47min
September 16, 2025 Someone Has to Obsess Over the Rivets: The Detail That Protects a $1.6bn Trial
Steve Sanghera on Inventus, Purpose-Built Trial Devices & Why Someone Must Obsess Over the Rivets | Pharma Prescribed
Steve Sanghera — CEO of Inventus — joins Adam Walker for a conversation about purpose-built clinical trial devices, global connectivity and why this industry needs someone obsessing over the rivets.
Steve came from mobile telecoms and finance. During COVID, a lost contract with Motorola led to a question: who needs this many devices? The answer was clinical trials. Half a million devices later, Inventus is the only dedicated clinical data plan operator in life sciences — carrier-agnostic connectivity across 135 countries, purpose-built hardware for patients and sites, and zero tolerance for the kind of failure rates consumer tech accepts.
His sister was diagnosed with MS at 19. She's 42 now, in a wheelchair. Inventus wasn't built because of that — but it drives everything Steve does today.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/5V4MJJPemxVcC8zl0WOvWZ?si=1c9e14455bee4dc2
Apple Podcasts → https://podcasts.apple.com/us/podcast/steve-sanghera-on-inventus-purpose-built-trial-devices/id1829715970?i=1000727055724
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://pharmaprescribed.podbean.com/
📖 WHAT WE COVER
- The Motorola loss that became the founding story of Inventus
- 500,000 devices deployed globally — zero consumer returns
- One world, one device: purpose-built for clinical trials, not repurposed consumer tech
- The only clinical data plan operator: 450 carriers, 135 countries, no SIM cards
- BYOD vs provisioned: why bring your own device is a cost saving, not a solution
- Designing for Doris from Texas: 85, not tech savvy, possibly impaired
- 586 languages on every device — four times more than any competitor
- The rivets analogy: everyone builds the plane, Inventus provides the rivets
- Service excellence with zero tolerance for failure in clinical trials
- His sister's MS diagnosis at 19 — and declining every trial offered
- The stigma around clinical trials and why it still stops families
- 70 employees, offices in UK, EU, China, Hong Kong and the US
- AstraZeneca's David Loughborough joining as Chief Strategy Officer
- Inventus 2.0: AI, connected health and preventative care roadmap
- "Build a business I can't run anymore" — that means success
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Steve Sanghera — CEO of Inventus
2:00 Lockdown, Motorola and the accidental entry into clinical trials
4:00 Purpose-built devices: why consumer tech doesn't work
5:00 One world, one device — and the ecosystem behind it
6:00 Patients, sites and sponsors: the three pillars
8:00 BYOD vs provisioned — cost saving vs real solution
9:00 Half the cost, full the value
10:00 The clinical data plan operator: 450 carriers, 135 countries
12:00 One product accessed globally — no SIM cards
13:00 Service excellence: every client and key hire comes via referral
14:00 Zero percent failure tolerance vs consumer 3-5%
15:00 Regulation, compliance and learning the language of life sciences
17:00 The biggest challenge: finding someone who cares about the rivets
18:00 The rivets analogy: protecting $1.6 billion per trial
20:00 Designing for Doris: user interface, font size, 586 languages
22:00 NHS app frustrations and simplifying complexity
24:00 From five people to 70 — three UK offices, EU, China, US
25:00 New leadership: COO, CSO from AstraZeneca, CPO from BT
27:00 "Our accountant joined us — that tells you the numbers are real"
28:00 His sister's MS diagnosis at 19 and the trials they declined
30:00 Clinical trial stigma and what must change
32:00 AI: don't jump on it, mould it for clinical trials
34:00 Inventus 2.0: building the oven, figuring out how to cook
37:00 "Build a business I can't run anymore"
38:00 The All Blacks: leaving the shirt in a better place
39:00 Quick-fire: should have started earlier
40:00 Integrity, loyalty, hard work — and shopping
41:00 Golden rule: be honest and transparent
👤 ABOUT STEVE SANGHERA
CEO of Inventus. Purpose-built clinical trial devices and the only dedicated clinical data plan operator in life sciences.
🌐 Search "Inventus clinical trials" or "Steve Sanghera" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#SteveSanghera #Inventus #ClinicalTrials #MedicalDevices #PharmaPrescribed #AdamWalker #ClinicalTechnology #BYOD #PatientDevices #GlobalConnectivity #eSIM #LifeSciences #DrugDevelopment #PurposeBuilt #ServiceExcellence
...more
42min
August 22, 2025 2,000 Videos In: Why Trust Is the Ultimate Cheat Code in Healthcare
Dr. Berry Pierre on Main Character Energy, 2k YouTube Vids & Trust in Healthcare | Pharma Prescribed
Dr. Berry Pierre — board certified internist, host of the Lunch and Learn Podcast and digital health educator with over 2,000 YouTube videos — joins Adam Walker for one of the most energising conversations on the Pharma Prescribed Podcast.
Dr. Berry grew up in a Haitian community in the US, inspired by his childhood paediatrician Dr. Gasstone — the community physician who spoke their language and their truth. He decided at elementary school he wanted to be a doctor, never had a plan B, and never looked back. Fifteen years into clinical practice, he realised he couldn't help the whole community one patient at a time — so he started going live on Facebook during his lunch hour, twice a week, and built a digital health empire from there.
His golden rule: be trustworthy, be responsible, and add a pinch of confidence.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/0NocvLEShLPb2vJQdR5zN3?si=-acv27f3RlmRdX0fALfnnQ
Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-dr-berry-pierre-fact-versus/id1829715970?i=1000723106007
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://www.podbean.com/eas/pb-rm3xz-193fa5c
📖 WHAT WE COVER
- Dr. Gasstone: the Haitian community physician who inspired everything
- Main character energy — and where it comes from
- Systematic barriers: time, insurance, language and cultural competency
- The lunch hour cheat code: Facebook Live on Tuesdays and Thursdays
- 2,000+ YouTube videos and the Lunch and Learn Podcast at 400+ episodes
- Patients trusting him before they've even met him
- Vaccine hesitancy, pop culture and public health
- Cultural competency in Haitian and underserved communities
- The future of AI in community health education
- Be okay with not being right 100% of the time — advice to a younger self
- Speed, reliability and the ability to build trust — team qualities
- PlayStation, strategy games and Harry Potter as decompression
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Dr. Berry Pierre — board certified internist
2:00 Main character energy and Dr. Gasstone
3:00 No plan B — doctor from elementary school
4:00 Systematic barriers: time, insurance, language
5:00 The lunch hour cheat code: Facebook Live twice a week
6:00 One to many — scaling trust through content
8:00 Serving Haitian communities and cultural competency
12:00 Vaccine hesitancy and pop culture meets public health
16:00 2,000 YouTube videos and what keeps him going
20:00 AI in community health education
24:00 Why trust is the ultimate cheat code
28:00 Comparing US and UK healthcare access
32:00 The Empower Yourself for Better Health series
36:00 Quick-fire: be okay with not being right all the time
38:00 Speed, reliability and building trust as team values
40:00 PlayStation, God of War and Harry Potter
42:00 Golden rule: trustworthy, responsible, pinch of confidence
43:00 drberrypierre.com and closing thanks
👤 ABOUT DR. BERRY PIERRE
Board certified internist. Host of the Lunch and Learn with Berry Podcast (400+ episodes). 2,000+ YouTube videos. 15+ years of clinical practice.
🌐 https://www.drberrypierre.com
💼 Search "Dr Berry Pierre" on LinkedIn and YouTube
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#DrBerryPierre #LunchAndLearn #DigitalHealth #PublicHealth #PharmaPrescribed #AdamWalker #PatientEducation #CulturalCompetency #HealthEquity #VaccineHesitancy #CommunityHealth #MainCharacterEnergy #LifeSciences #YouTube #Podcast
...more
50min
August 17, 2025 Treat People Like Athletes, Not Assets: The CRO Built on Wellbeing
Leigh Fell on Caritas Bioscience, Corporate Athleticism & Wellbeing Isn't a Perk | Pharma Prescribed
Leigh Fell — founder of Caritas Bioscience, Sunday Times 25 Women Succeeding in 2025 and champion of corporate athleticism — joins Adam Walker for a conversation about building a purpose-driven CRO, burnout, wellbeing and what it means to treat people the way you'd want to be treated.
Leigh started in clinical operations running oncology trials, experienced burnout as a CRA, and vowed to build a company that looked after its people. In 2017 she founded Caritas — named after the Latin motto of both her and Adam's schools meaning love for all. The company now specialises in neurology and oncology trials, has achieved 30% better employee retention through its wellbeing-first culture, and partners with pharma innovators in areas of profound unmet need.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/7vUuR5kNdUOBfb47OEIcBW?si=QPE0V-VpSvWW3RQ-WSVjrg
Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-leigh-fell-ceo-of/id1829715970?i=1000722267719
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://pharmaprescribed.podbean.com/
📖 WHAT WE COVER
- Burnout as a CRA — and the vow to build a company that looks after people
- Caritas: ex corde caritas — love from the heart
- GW Pharma, cannabinoids and paediatric epilepsy — the project that shaped the mission
- Every illness in her family was neurological: epilepsy, Alzheimer's, stroke, depression
- Corporate athleticism: treating employees like athletes, not assets
- 30% better employee retention through wellbeing-first culture
- Gratitude sessions at the start of every team call
- Sunday Times 25 Women Succeeding in 2025
- Bringing oncology lessons into neurology trials
- AI and the next generation: who teaches the juniors when bots do the groundwork?
- Do what you love rather than what seems sensible
- Treat others the way you'd want to be treated — the golden rule
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Leigh Fell — founder of Caritas Bioscience
2:00 Physiology, sports science and nutrition at Glasgow
3:00 Falling into clinical research and starting in data management
4:00 Burnout as a CRA — the original why
5:00 Founding Caritas in 2017: love for all
6:00 GW Pharma and the family connection to neurology
8:00 Oncology to neurology to all therapeutic areas
10:00 Corporate athleticism and employee wellbeing
12:00 Gratitude sessions, aerial yoga and team bonding
14:00 30% better retention — what wellbeing culture delivers
16:00 Sunday Times feature and what recognition means
18:00 Adapting through pandemic, market shifts and growth
20:00 Oncology lessons applied to neurology
24:00 AI in clinical operations — who trains the next generation?
28:00 The consultant-to-founder transition
30:00 Quick-fire: do what you love, not what seems sensible
32:00 Kindness, initiative and enthusiasm in hiring
33:00 Gun dog training, drawing and walks in the hills
34:00 Golden rule: treat others how you'd want to be treated
👤 ABOUT LEIGH FELL
Founder of Caritas Bioscience. Sunday Times 25 Women Succeeding in 2025. 17 years in clinical development. Neurology and oncology specialist CRO.
🌐 https://www.caritasbioscience.com
💼 Search "Leigh Fell" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#LeighFell #CaritasBioscience #ClinicalOperations #Wellbeing #PharmaPrescribed #AdamWalker #CorporateAthleticism #SundayTimes #WomenInLeadership #CRA #Neurology #Oncology #LifeSciences #ClinicalResearch #FemaleFounder
...more
35min
August 12, 2025 Almost Everyone in This Industry Arrived by Accident. Here's What Keeps Them
Anders Mortin on Triticon, Knowledge World & 25 Years of Accidental Pharma | Pharma Prescribed
Anders Mortin — co-founder of Triticon and builder of the Knowledge World platform — joins Adam Walker for a conversation about eClinical consulting, knowledge sharing and what it means to build a company that values being useful over being big.
Anders holds a Master's in engineering physics from Lund University and fell into clinical data management by accident — a handball teammate needed extra hands for data entry at a small CRO. A brief escape to laser optics ended when the company collapsed after 26 days. He went back to pharma and never left. Twenty-five years later, he and his partners run Triticon from a hospital in Copenhagen with meeting rooms themed as a hunting cabin, Bali and Nasa.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/2OET5ah95hOOM826LcWOfx?si=LeZPBjYuS4iGv5r-OCbbkQ
Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-anders-mortin-co-founder/id1829715970?i=1000721650878
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://www.podbean.com/eas/pb-x9giy-192fff8
📖 WHAT WE COVER
- Handball, data entry and the accidental career in pharma
- 26 days in laser optics before the company collapsed
- Building Triticon: eClinical consulting from Copenhagen
- Knowledge World: a platform for sharing operational knowledge across pharma
- Why most people in biometrics ended up here by accident
- The hunting cabin meeting room and Danish work culture
- CrossFit, garden sheds and doing something tangible with your hands
- Be of value — the golden rule
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Anders Mortin — co-founder of Triticon
2:00 The hunting cabin meeting room in a Copenhagen hospital
3:00 Handball, data entry and slipping into pharma by accident
4:00 26 days in laser optics — and the company that collapsed
6:00 Paper CRFs, handwritten queries and the old days
8:00 Building Tricon in Copenhagen with his partners
10:00 Knowledge World: the platform for operational knowledge sharing
14:00 Why pharma needs better knowledge transfer
18:00 Pioneers, feedback and building in public
22:00 AI, LLMs and what changes for eClinical consulting
28:00 The consultant's dilemma: automation vs billable hours
34:00 Mentors and the balance between nerd and communicator
38:00 Quick-fire: family first, CrossFit, nature and garden sheds
44:00 Golden rule: be of value — and the tangible life
46:00 triticon.com, Knowledge World and closing thanks
👤 ABOUT ANDERS MORTIN
Co-founder of Triticon, a Copenhagen-based eClinical consultancy. Builder of Knowledge World. Master's in engineering physics. 25+ years in clinical data management.
🌐 https://www.tricon.com
💼 Search "Anders Mortin" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#AndersMortin #Triticon #KnowledgeWorld #eClinical #PharmaPrescribed #AdamWalker #ClinicalDataManagement #Copenhagen #LifeSciences #ClinicalResearch #PharmaConsulting #DanishPharma #KnowledgeSharing #CrossFit #EngineeringPhysics
...more
48min
August 05, 2025 The 'Digital Twin' That Tests Your Drug Before Any Patient Does
Belma Alispahic on SimCell, Digital Twins for Bioprocessing & Why AI Isn't Optional Anymore | Pharma Prescribed
Belma Alispahic — co-founder and Chief Scientific Officer of Analysismode — joins Adam Walker for a conversation about AI-powered bioprocess development, digital twins and what happens when a curious kid from Bosnia decides she can't be an astronaut.
Belma has a Master's in applied biotechnology from Uppsala University and co-founded Analysismode during COVID. The company's platform, SimCell, uses AI and digital twins to simulate bioprocesses — helping pharma reduce manufacturing costs, shorten time to market and make smarter development decisions without running every experiment in the lab.
She recently spoke at the 9th Bioproduction Congress in France. Her message: AI isn't optional — it's essential.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify →https://open.spotify.com/episode/3gOM0ul9a0LCim6N734VOi?si=dWoW0w28TkaMtiLdlHeWXg
Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-podcast-with-belma-alispahic-ceo/id1829715970?i=1000720744446
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://www.podbean.com/eas/pb-uc9ru-19261e7
📖 WHAT WE COVER
- From curious kid in Bosnia to biotech co-founder in Sweden
- Astronaut, pianist or biologist — the career shortlist
- SimCell: digital twins for bioprocess development
- Why therapies cost too much — and how AI reduces manufacturing cost
- ChatGPT as the inflection point: when AI went from niche to everywhere
- AI won't replace pharma scientists — but it will change how they work
- Paper notebooks, Excel sheets and the data lake problem
- Big pharma hiring AI teams massively — what that means for startups
- Conservative industry vs the speed of AI adoption
- Bioproduction Congress in France: AI isn't optional
- Be honest, be weird — the golden rule
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Belma Alispahic — CSO of Analysismode
2:00 Bosnia, curiosity and the astronaut dream
3:00 Biology as the closest thing to space
4:00 Co-founding Analysismode during COVID
5:00 SimCell: digital twins for bioprocesses
7:00 Why therapies cost too much
9:00 ChatGPT as the inflection point for pharma AI
11:00 Big pharma hiring AI teams massively
13:00 Paper notebooks, Excel and pharma's data problem
15:00 AI augmenting not replacing scientists
18:00 Bioprocessing industry: niche but critical
20:00 Bioproduction Congress in France
22:00 How SimCell works: dashboards not code
25:00 Conservative industry vs AI speed
28:00 Being a startup in a regulated world
30:00 The Balkans, accountability and growing up fast
32:00 Quick-fire: curiosity, integrity, ownership and empathy
34:00 Music, piano and touching grass after remote work
36:00 Golden rule: be honest, be weird — take up space
👤 ABOUT BELMA ALISPAHIC
Co-founder and CSO of Analysismode. Master's in applied biotechnology (Uppsala University). Builder of SimCell. Speaker at the 9th Bioproduction Congress.
🌐 https://www.analysismode.com
💼 Search "Belma Alispahic" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#BelmaAlispahic #Analysismode #SimCell #DigitalTwins #Bioprocessing #PharmaPrescribed #AdamWalker #AIinPharma #Biotech #BioprocessDevelopment #Uppsala #Bosnia #FemaleFounder #DeepTech #BioproductionCongress
...more
40min
July 30, 2025 The Trial That Failed His Mother — So He Rebuilt the System
Wessam Sonbol on Delve Health & Why Clinical Trials Failed His Mother | Pharma Prescribed
Wessam Sonbol — founder and CEO of Delve Health — joins Adam Walker for a conversation about decentralised trials, patient concierge teams and what happens when clinical research failed your mother and you decide to fix it.
Wessam's mom was a cancer patient who struggled to join a clinical trial — not because the science failed, but because the process did. The paperwork, the jargon, the drives, the system. That became the founding story of Delve Health — a platform supporting decentralised and hybrid clinical trials in 65+ languages, with wearables, televisits, AI-powered tools and a concierge team that speaks to 1,500–2,000 patients a week.
30% reduction in dropout. 20% faster trial completion. 40+ people across US, Belize, Egypt and Pakistan.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/61S4aebMQMjWsEZYRqUo0N?si=Ae5VOQkrQ4KqDxHvWgO7rw
Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-wessam-sonbol-ceo-of-delve/id1829715970?i=1000719799789
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://www.podbean.com/eas/pb-xqmxt-191c857
📖 WHAT WE COVER
- His mother's cancer and the system that failed her — the founding story
- 1,500–2,000 patients spoken to every week by the concierge team
- 65+ languages supported on one platform
- 30% dropout reduction and 20% faster completion
- Why pushing out another ePRO diary is not the answer
- tctmd.com, global registries and the early career by accident
- Clinical Systems Consultants: scaling across three continents
- Perter.io: AI and NLP cutting research time by 40%
- Wearables, televisits and the true meaning of decentralised
- Oncology and Alzheimer's: the hardest trials to retain patients in
- Real world evidence and where the future of data is heading
- The hustle as a golden rule — and why it beats being the smartest
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Wessam Sonbol — founder of Delve Health
3:00 His mother's cancer and the process that failed her
4:00 Founding Delve Health: making trials accessible
5:00 Early career by accident: EMR data and cardiovascular marketing
6:00 tctmd.com and the global registry platform
8:00 Patient concierge: 1,500–2,000 patients spoken to every week
10:00 Why another diary or PRO isn't the final answer
12:00 65+ languages and true global accessibility
14:00 30% dropout reduction and 20% faster completion
16:00 Wearables, televisits and AI-powered tools
18:00 Oncology and Alzheimer's: the hardest trials for retention
20:00 Clinical Systems Consultants and scaling across three continents
22:00 Perter.io: AI and NLP for research intelligence
24:00 40+ people across US, Belize, Egypt and Pakistan
26:00 Delve as outcomes delivery, not just a platform
28:00 The future: real world evidence and big data sets
32:00 Quick-fire: don't stress — it will be okay
34:00 Persistence, the hustle, stay hungry and stay humble
36:00 Hanging out with the kids
37:00 Golden rule: the hustle — go after what you want
38:00 delvehealth.com and closing thanks
👤 ABOUT WESSAM SONBOL
Founder and CEO of Delve Health. 25+ years in clinical research and healthcare technology. Founder of Clinical Systems Consultants. Co-developer of Perter.io.
🌐 https://www.delvehealth.com
💼 Search "Wessam Sonbol" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#WessamSonbol #DelveHealth #DecentralisedTrials #DCT #PharmaPrescribed #AdamWalker #PatientCentric #ClinicalTrials #HealthTech #Wearables #Televisit #AIinPharma #ClinicalResearch #LifeSciences #PatientRetention
...more
38min

FAQs about Adam Walker’s Pharma Prescribed Podcast:

How many episodes does Adam Walker’s Pharma Prescribed Podcast have?

The podcast currently has 55 episodes available.